Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,146 | -19,109 | -1,909 | -912 | -161 |
| Other Working Capital | -1,304 | 478 | 248 | -36 | 185 |
| Other Operating Activity | 22,207 | 14,156 | 1,012 | 431 | -1,272 |
| Operating Cash Flow | $-8,242 | $-4,474 | $-650 | $-517 | $-1,247 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,380 | 4,900 | 400 | 350 | 1,100 |
| Debt Repayment | -468 | -468 | N/A | N/A | N/A |
| Common Stock Issued | 6,889 | 6,889 | 8,067 | 263 | N/A |
| Other Financing Activity | -489 | -195 | 0 | 0 | 0 |
| Financing Cash Flow | $20,313 | $11,126 | $8,467 | $613 | $1,100 |
| Beginning Cash Position | 194 | 194 | 194 | 194 | 342 |
| End Cash Position | 12,265 | 6,846 | 8,012 | 290 | 194 |
| Net Cash Flow | $12,071 | $6,652 | $7,818 | $96 | $-147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,242 | -4,474 | -650 | -517 | -1,247 |
| Free Cash Flow | -8,242 | -4,474 | -650 | -517 | -1,247 |